Surveillance for dengue and dengue-associated neurologic syndromes in the United States

American Journal of Tropical Medicine and Hygiene

Volumn 92, Issue 5, 2015, Pages 996-998

  Waterman, Stephen H ^a   Margolis, Harold S ^a   Sejvar, James J ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

AEDES AEGYPTI; ARTICLE; ASEPTIC MENINGITIS; CLINICAL FEATURE; DENGUE; DENGUE VIRUS 2; DISEASE SURVEILLANCE; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RATE; LABORATORY TEST; PUBLIC HEALTH; RETROSPECTIVE STUDY; UNITED STATES; VIRUS TRANSMISSION; AEDES; ANIMAL; COMPLICATION; DENGUE VIRUS; DISEASE CARRIER; EPIDEMIOLOGICAL MONITORING; ISOLATION AND PURIFICATION; MENINGITIS, ASEPTIC; TRANSMISSION; VIROLOGY;

AEDES AEGYPTI; DENGUE VIRUS;

AEDES; ANIMALS; DENGUE; DENGUE VIRUS; ENCEPHALITIS; EPIDEMIOLOGICAL MONITORING; HUMANS; INSECT VECTORS; MENINGITIS, ASEPTIC; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84929119632     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0016     Document Type: Article

References (23)

1. Gubler DJ, 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496.
2. Solomon T, Minh Dung N, Vaughn D, Kneen R, Thao LTT, Raengsakulrach B, Loan HT, Day NPJ, Farrar J, Myint KSA, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurologic manifestations of dengue infection. Lancet 355: 1053-1059.
3. Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED, 2001. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 65: 848-851.
4. Domingues RB, Kuster GW, Onuki-Castro FL, Souza VA, Levi JE, Pannuti CS, 2008. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci 267: 36-40.
5. Eisen L, Moore CG, 2013. Aedes (Stegomyia) aegypti in the Continental United States: a vector at the cool margin of its geographic range. J Med Entomol 50: 467-478.
6. Clark GG, 2008. Dengue and dengue hemorrhagic fever in northern Mexico and south Texas: do they really respect the border? Am J Trop Med Hyg 78: 361-362.
7. Centers for Disease Control and Prevention, 2010. Locally acquired dengue - Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 59: 577-581.
8. Centers for Disease Control and Prevention, 2010. Travel-associated dengue surveillance - United States, 2006-8. MMWR Morb Mortal Wkly Rep 59: 715-719.
9. Wright WF, Pritt BS, 2012. Update: the diagnosis and management of dengue virus infection in North America. Diagn Microbiol Infect Dis 73: 215-220.
10. Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, Medina F, Colón C, Margolis H, Muñoz-Jordán JL, 2013. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis 7: e2311.
11. Murray KO, Rodriguez LF, Herrington E, Kharat V, Vasilakis N, Walker C, Turner C, Khuwaja S, Arafat R, Weaver SC, Martinez D, Kilborn C, Bueno R, Reyna M, 2013. Identification of dengue fever cases in Houston, Texas, with evidence of autochthonous transmission between 2003 and 2005. Vector Borne Zoonotic Dis 13: 835-845.
12. Ackerman T, October 9, 2013. Dengue virus identified in Houston: potentially lethal disease carried by mosquitoes found in city. Houston Chronicle. Available at: http://www.chron.com/news/health/article/Dengue-virus-identified-in-Houston-4883103.php.
13. Gustafson TA, 2013. Houston, We Have Dengue Fever. Available at: http://www.npr.org/blogs/health/2013/10/16/235628882/houston-we-have-dengue-fever. Accessed April 4, 2014.
14. Vazquez S, Hafner G, Ruiz D, Calzada N, Guzman MG, 2007. Evaluation ofimmunoglobulin M and G capture anzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections. J Clin Virol 39: 194-198.
15. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Pelegrino JL, Vazquez S, Artsob H, Drebot M, Gubler DJ, Halstead SB, Guzman MG, Margolis H, Nathanson CM, Rizzo Lic NR, Bessoff KE, Kliks S, Peeling RW, 2009. Evaluation of commercially available anti-dengue virus immunogloblulin M tests. Emerg Infect Dis 15: 436-440.
16. Reiter P, Lathrop S, Bunning M, Biggerstaff BJ, Singer D, Tiwari T, Baber L, Amador M, Thirion J, Hayes J, Seca C, Mendez J, Ramirez B, Robinson J, Rawlings J, Vorndam V, Waterman S, Gubler D, Clark G, Hayes E, 2003. Texas life-style limits transmission of dengue virus. Emerg Infect Dis 9: 86-89.
17. Ramos MM, Mohammed H, Zielinski-Gutierrez E, Hayden MH, Robles Lopez JL, Fournier M, Rodriguez Trujillo A, Burton R, Brunkard JM, Anaya-Lopez L, Abell Banicki A, Kuri Morales P, Smith B, Muñoz JL, Waterman SH; The Dengue Serosurvey Working Group, 2008. Epidemic dengue and dengue hemor-rhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 78: 364-369.
18. Centers for Disease Control and Prevention, 2007. Dengue hemorrhagic fever - U.S. - Mexico Border, 2005. MMWR Morb Mortal Wkly Rep 56: 785-789.
19. Kanade T, Shah I, 2011. Dengue encephalopathy. J Vector Borne Dis 48: 180-181.
20. Lum LC, Lam SK, Choy YS, George R, Harun F, 1996. Dengue encephalitis: a true entity? Am J Trop Med Hyg 54: 256-259.
21. Carod-Artal FJ, Wichmann O, Farrar J, Gascón J, 2013. Neurologic complications of dengue virus infection. Lancet Neurol 12: 906-919.
22. World Health Organization, 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control, 3rd Ed. Geneva: World Health Organization.
23. Halstead SB, 2012. Dengue vaccine development: a 75% solution? Lancet 380: 1535-1536.